MEN1 and acute myeloid leukemia: This altered leukemogenic program common between NPM1c and KMT2Ar led to the hypothesis that menin is possibly associated with dysregulated expression of HOX and MEIS in NPM1-m AML, and targeting menin could be a therapeutic strategy (Figure 4).